Clinical Oncology Education

A Paradigm Shift in Hematology: Less-Intensive Therapy Outperforms Standard Chemotherapy in Newly Diagnosed AML

• Clinical Oncology Education

A Paradigm Shift in Hematology: Less-Intensive Therapy Outperforms Standard Chemotherapy in Newly Diagnosed AML

Laily UPN September 8, 2026

In a landmark development for hematological oncology, researchers from the Mass General Brigham Cancer Institute have unveiled...

Read More Read more about A Paradigm Shift in Hematology: Less-Intensive Therapy Outperforms Standard Chemotherapy in Newly Diagnosed AML

Advancing the Frontier: A Preview of the 19th Annual Royal Marsden Breast Cancer Meeting

• Clinical Oncology Education

Advancing the Frontier: A Preview of the 19th Annual Royal Marsden Breast Cancer Meeting

Lina Irawan September 8, 2026

As the global oncology community prepares to convene in London on 2 October 2026, the 19th Annual...

Read More Read more about Advancing the Frontier: A Preview of the 19th Annual Royal Marsden Breast Cancer Meeting

Redefining Precision in Triple-Negative Breast Cancer: Can Early PET Imaging Transform Treatment Pathways?

• Clinical Oncology Education

Redefining Precision in Triple-Negative Breast Cancer: Can Early PET Imaging Transform Treatment Pathways?

Nana September 7, 2026

In the landscape of oncology, Triple-Negative Breast Cancer (TNBC) remains one of the most challenging diagnoses. Known...

Read More Read more about Redefining Precision in Triple-Negative Breast Cancer: Can Early PET Imaging Transform Treatment Pathways?

Navigating the Intersection: The Global Menopause and Cancer Conference 2026 Set to Redefine Patient Care

• Clinical Oncology Education

Navigating the Intersection: The Global Menopause and Cancer Conference 2026 Set to Redefine Patient Care

Lina Irawan September 6, 2026

The intersection of menopause and cancer care remains one of the most complex, rapidly evolving, and emotionally...

Read More Read more about Navigating the Intersection: The Global Menopause and Cancer Conference 2026 Set to Redefine Patient Care

Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care

• Clinical Oncology Education

Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care

Rifan Muazin September 4, 2026

The landscape of metastatic HER2-positive breast cancer is undergoing a seismic shift. For over a decade, the...

Read More Read more about Redefining the First-Line Paradigm: The Impact of DESTINY-Breast09 on HER2-Positive Breast Cancer Care

A New Frontier in Oncology: ‘Tissue-Free’ Blood Test Promises Earlier Detection of Breast Cancer Recurrence

• Clinical Oncology Education

A New Frontier in Oncology: ‘Tissue-Free’ Blood Test Promises Earlier Detection of Breast Cancer Recurrence

Lina Hope September 4, 2026

In a significant breakthrough for oncology, researchers at The Institute of Cancer Research (ICR), London, have validated...

Read More Read more about A New Frontier in Oncology: ‘Tissue-Free’ Blood Test Promises Earlier Detection of Breast Cancer Recurrence

The Hidden Cost of Convenience: New Research Links Ultra-Processed Foods to Increased Prostate Cancer Risk

• Clinical Oncology Education

The Hidden Cost of Convenience: New Research Links Ultra-Processed Foods to Increased Prostate Cancer Risk

Ali Ikhwan September 4, 2026

In the landscape of modern American nutrition, convenience has long been king. From carbonated soft drinks and...

Read More Read more about The Hidden Cost of Convenience: New Research Links Ultra-Processed Foods to Increased Prostate Cancer Risk

Beyond Genetics: Breakthrough "Tumor-on-a-Chip" Technology Revolutionizes Glioblastoma Treatment

• Clinical Oncology Education

Beyond Genetics: Breakthrough "Tumor-on-a-Chip" Technology Revolutionizes Glioblastoma Treatment

Nila Kartika Wati September 4, 2026

In the high-stakes world of neuro-oncology, glioblastoma (GBM) remains one of the most formidable adversaries. As the...

Read More Read more about Beyond Genetics: Breakthrough "Tumor-on-a-Chip" Technology Revolutionizes Glioblastoma Treatment

Breakthrough in Bladder Cancer Diagnostics: New Genomic Urine Test Shows Near-Perfect Accuracy in NHS Trial

• Clinical Oncology Education

Breakthrough in Bladder Cancer Diagnostics: New Genomic Urine Test Shows Near-Perfect Accuracy in NHS Trial

Iffa Jayyana September 3, 2026

A landmark study published in European Urology Oncology has revealed that a non-invasive genomic urine test, GALEAS...

Read More Read more about Breakthrough in Bladder Cancer Diagnostics: New Genomic Urine Test Shows Near-Perfect Accuracy in NHS Trial

Targeting the “Undruggable”: The Paradigm Shift in Metastatic Pancreatic Cancer Treatment

• Clinical Oncology Education

Targeting the “Undruggable”: The Paradigm Shift in Metastatic Pancreatic Cancer Treatment

Jia Lissa September 3, 2026

Introduction: A New Dawn for PDAC Patients Pancreatic ductal adenocarcinoma (PDAC) has long been regarded as one...

Read More Read more about Targeting the “Undruggable”: The Paradigm Shift in Metastatic Pancreatic Cancer Treatment